Piramal Pharma Solutions launches rapid integrated approach ADCelerate
ADCelerate delivers Phase I appropriate antibody-drug conjugate (ADC) drug substance and drug product for Investigational New Drug (IND) submission
Peter Deyoung Contract Development Piramal Pharma Solutions Manufacturing Organization Mumbai Based Contract Development Chief Executive Officer
Source: biospectrumindia.com